Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-05-28

FDA Approved: BESIVANCE — Original Application (Bausch & Lomb Americas Inc.)

View source ↗

Summary

The FDA approved Besivance (besifloxacin) in its original application for the treatment of bacterial conjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BESIVANCE (besifloxacin)

Snippet

ORIG AP for BESIVANCE (BESIFLOXACIN)